HKEX: 867
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
View original source (HKEXnews)Company analysis
Earlier from China Medical System
- Change of company name of singapore share transfer agent
- CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China
- CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)
- CMS's (867.HK/8A8.SG) Self-developed Innovative INHBE-Targeting siRNA Drug CMS-D008 Presents Its Preclinical Results at the ADA Scientific Sessions